BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7085259)

  • 1. Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.
    Sánchez-Crespo M; Alonso F; Iñarrea P; Alvarez V; Egido J
    Immunopharmacology; 1982 Apr; 4(2):173-85. PubMed ID: 7085259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-platelet-mediated vascular actions of 1-O-alkyl-2-acetyl-sn-3-glyceryl phosphorycholine (a synthetic PAF).
    Sánchez Crespo M; Alonso F; Iñarrea P; Egido J
    Agents Actions; 1981 Dec; 11(6-7):565-6. PubMed ID: 7340443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.
    Prancan A; Lefort J; Barton M; Vargaftig BB
    Eur J Pharmacol; 1982 May; 80(1):29-35. PubMed ID: 7095003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
    Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
    J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
    Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS
    Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes.
    Bonnet J; Loiseau AM; Orvoen M; Bessin P
    Agents Actions; 1981 Dec; 11(6-7):559-62. PubMed ID: 7340441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs.
    Fiedler VB; Mardin M; Abram TS
    Basic Res Cardiol; 1987; 82(2):197-208. PubMed ID: 3606544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
    Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
    Benveniste J; Chignard M; Le Couedic JP; Vargaftig BB
    Thromb Res; 1982 Mar; 25(5):375-85. PubMed ID: 6803388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations.
    Benveniste J; Boullet C; Brink C; Labat C
    Br J Pharmacol; 1983 Sep; 80(1):81-3. PubMed ID: 6652376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
    Touqui L; Jacquemin C; Vargaftig BB
    Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor (PAF-acether): present status.
    Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):542-4. PubMed ID: 6176101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of a role for PAF-acether in the pathophysiology of the shock state.
    Sanchez Crespo M; Inarrea P; Nieto ML; Fernandez-Gallardo S
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
    Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
    J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
    Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
    Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
    Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
    Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
    Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.